Tenet Healthcare (THC) Reiterated at Overweight by Cantor Fitzgerald After HCIT Survey
April 15, 2026 7:43 AM
Cantor Fitzgerald analyst Sarah James reiterated an Overweight rating and $245.00 price target on Tenet Healthcare (NYSE: THC).The analyst commented ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
